The record supports recurrent, treatment-resistant migraine with episodic inability to sustain screen use, concentration, and reliable attendance. It does not yet quantify the frequency and duration of incapacitating episodes consistently enough to support every asserted work restriction. The adverse peer review relies heavily on normal interictal neurological examinations and does not adequately address longitudinal headache frequency, rescue-medication use, documented work interruption, or medication effects. Treating-provider clarification is needed before the administrative record closes.
4–6 migraine days/month; working full time; episodic triptan use.
12–15 migraine days/month; preventive therapy changed; two urgent-care visits.
Neurologist documents 3–4 severe episodes weekly, photophobia, nausea, and need to lie in a dark room; employer notes repeated early departures.
CGRP therapy reduces severe episodes, but diary and pharmacy records remain incomplete.
| Functional domain | Supporting evidence | Contrary / limiting evidence | Assessment |
|---|---|---|---|
| Screen tolerance | Photophobia documented; claimant and employer describe screen-triggered worsening | No formal ergonomic or visual-tolerance assessment | Partially supported |
| Concentration / pace | Neurology notes cognitive slowing during severe episodes; topiramate side effects documented | Normal brief office cognition between episodes | Episodic support |
| Attendance reliability | Employer attendance log; urgent-care visits; frequent rescue-medication use | Headache diary incomplete for 7 of 12 weeks | Needs quantification |
| Physical sitting / lifting | No material restriction documented | Normal strength and gait | Not limiting |
| Decision-making safety | No documented dangerous errors | Claimant reports slowed processing during attacks | Not established |
| Peer-review statement | Record issue | Medical analysis |
|---|---|---|
| “Normal neurological examinations demonstrate no functional impairment.” | Examinations occurred between attacks. | A normal interictal examination does not by itself address episodic migraine frequency, duration, recovery time, photophobia, nausea, or attendance effects. |
| “No objective evidence supports cognitive restriction.” | Medication side effects and episode-related slowing were documented but not analyzed. | The record lacks formal cognitive testing, but the reviewer should distinguish absence of testing from affirmative evidence of sustained full function. |
| “Treatment improved symptoms.” | Improvement was partial and diary documentation incomplete. | Partial response does not establish full-time reliability. The relevant question is residual frequency and functional impact. |
Multiple preventive trials, urgent visits, employer attendance evidence, and specialist notes support a substantial change from baseline.
Provider notes alternate between weekly estimates, monthly counts, and qualitative descriptions. The diary is incomplete.
Normal strength, gait, speech, and brief cognition should be acknowledged rather than ignored; the claim turns on sustained reliability, not continuous neurological deficit.
| Missing evidence | Why it matters | Action |
|---|---|---|
| Complete 8–12 week headache diary | Quantifies frequency, duration, rescue use, recovery time, and work interruption | Obtain contemporaneous diary or reconcile existing entries. |
| Treating neurologist restriction rationale | Current note states “unable to work” without linking attacks to specific duties | Request duty-specific explanation supplied through counsel. |
| Medication side-effect timeline | Topiramate-related slowing is documented but dose changes and persistence are unclear | Clarify onset, dose relationship, current status, and alternatives. |
| Employer attendance and accommodation record | Helps test sustained reliability and failed work modifications | Include complete non-medical record where procedurally appropriate. |